CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby…

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Duloxetine Delayed-Release Capsules USP

Read the official FDA notice

Published
5 Feb 2025
Units affected
a) 6408 boxes and b)1488 boxes
Agency
FDA
Country
United States

The hazard

CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Duloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses (3x10 blister packs) NDC 0904-7043-04 and b) 100 Unit Doses (10x10 blister packs) NDC 0904-7043-61, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA.

Brand / company
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Codes / lots
Lot #: a) N01530, Exp. Date 01/2025; b) N01540, Exp. Date. 01/2025
Distribution
Nationwide within the United States
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 5 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.